Breaking News Instant updates and real-time market news.

GM

General Motors

$36.62

-0.25 (-0.68%)

, TM

Toyota

$143.53

-0.76 (-0.53%)

18:42
11/18/19
11/18
18:42
11/18/19
18:42

CA to halt purchase of GM, Toyota, Fiat Chrysler vehicles, Reuters reports

The state of California said it plans to halt all purchases of new vehicles for state government fleets from General Motors (GM), Toyota (TM), Fiat Chrysler (FCAU), and other car makers supporting U.S. President Donald Trump in a fight to strip the state of authority to regulate tailpipe emissions, Reuters' David Shepardson reports. Between 2016 and 2018, the state purchased $58.6M in vehicles from GM, $55.8M from Fiat Chrysler, $10.6M from Toyota, and $9M from Nissan (NSANY), Shepardson notes. "Removing vehicles like the Chevy Bolt and prohibiting GM and other manufacturers from consideration will reduce California's choices for affordable, American-made electric vehicles and limit its ability to reach its goal of minimizing the state government's carbon footprint, a goal that GM shares," said GM spokeswoman Jeannine Ginivan. Reference Link

GM

General Motors

$36.62

-0.25 (-0.68%)

TM

Toyota

$143.53

-0.76 (-0.53%)

FCAU

Fiat Chrysler

$15.63

-0.39 (-2.43%)

NSANY

Nissan

$0.00

(0.00%)

  • 19

    Nov

GM General Motors
$36.62

-0.25 (-0.68%)

11/05/19
LEHM
11/05/19
DOWNGRADE
Target $12
LEHM
Equal Weight
Barclays downgrades American Axle on limited earnings upside
Barclays analyst Brian Johnson downgraded American Axle (AXL) to Equal Weight from Overweight with an unchanged price target of $12. The analyst appreciates the company's progress on operational performance and launch cost reduction, but he sees limited upside to 2020 earnings estimates. Johnson thinks there is "little reason to be Overweight the stock" given the limited upside to 2020 earnings expectations as a result of General Motors' (GM) capacity constraints and late-cycle nature and its exposure to U.S. automotive.
10/30/19
FBCO
10/30/19
NO CHANGE
Target $47
FBCO
Outperform
GM earnings 'formally turned the page' on UAW strike, says Credit Suisse
Credit Suisse analyst Dan Levy raised his price target for General Motors to $47 from $46 and maintained an Outperform rating, saying the earnings release was important because it "formally turned the page" on the UAW strike. With the strike now in the rearview mirror, and with GM's steady state earnings power largely intact, Levy says he believes GM is well positioned and has an opportunity to position itself as one of the better stories in autoland given earnings growth and relatively more favorable end market exposures.
10/30/19
SBSH
10/30/19
NO CHANGE
SBSH
Buy
General Motors path to $76-$134 per share remains intact, says Citi
General Motors' Q3 results "provided another compelling proof-point of the uniqueness" of its North America franchise, led by a pickup truck story that is "still not well-understood," Citi analyst Itay Michaeli tells investors in a post-earnings research note. The question turns to whether GM shares "will again shrug off strong results or finally re-rate higher," questions the analyst. For his part, Michaeli believes GM's path to $76-$134 per share remains intact. He keeps a Buy rating on General Motors.
11/18/19
RBCM
11/18/19
NO CHANGE
Target $33
RBCM
Sector Perform
Navistar price target raised to $33 from $30 at RBC Capital
RBC Capital analyst Seth Weber raised his price target on Navistar (NAV) to $33 to reflect the multiple expansion across its peer group and calls the company's update last week regarding the impact of the GM (GM) autoworker strike as "unsurprising". The analyst notes that while the company projects its FY19 revenue and EBITDA to be at the low end of its prior guidance ranges, his FY20/21 estimates are "essentially unchanged", as he also maintains his Sector Perform rating on the stock.
TM Toyota
$143.53

-0.76 (-0.53%)

05/15/19
05/15/19
NO CHANGE

Trump plans to delay imposing tariffs on auto imports, Bloomberg reports
Publicly traded companies in the space include Daimler AG (DDAIF), Fiat Chrysler (FCAU), Ford (F), General Motors (GM), Honda (HMC), Nissan (NSANY), Toyota (TM), Volkswagen (VWAGY) and Tesla (TLSA).
05/15/19
MSCO
05/15/19
NO CHANGE
MSCO
Tariff delay a 'modest positive' for automakers, says Morgan Stanley
Morgan Stanley analyst Michael Zezas called media reports indicating that the U.S. plans to delay auto tariffs by up to 6 months a "modest positive" for the automaking group, stating that extra time somewhat reduces the probability of tariffs going into place but that the core impasse between the U.S. and EU - namely whether or not to include agricultural issues in negotiations - still remains and is the real driver of the tariff tension. The analyst, who noted that the U.S. retains the option to implement tariffs at any point within the 180 day delay, said he still thinks auto tariffs are likely to go into effect later this year. Publicly traded automakers that moved up following the headlines regarding the delay decision include Daimler AG (DDAIF), Fiat Chrysler (FCAU), Ford (F), General Motors (GM), Honda (HMC), Nissan (NSANY), Toyota (TM) and Volkswagen (VWAGY).
06/07/19
BOFA
06/07/19
NO CHANGE
BOFA
Buy
Toyota 'clearly more focused' on China business, says BofA/Merrill
BofA/Merrill analyst Kei Nihonyanagi maintained a Buy rating and $140.98 price target on Toyota Motor (TM) following The Nikkei's report that the automaker will partner with China's CATL, an automotive battery maker. In a research note to investors, the analyst says the report is somewhat "surprising," given Toyota announced a JV with Panasonic (PCRFY) earlier this year to produce automotive batteries for electric vehicles, but says Toyota is "clearly more focused" on its China business than before.
09/05/19
MSCO
09/05/19
DOWNGRADE
MSCO
Underweight
Toyota downgraded to Underweight from Equal Weight at Morgan Stanley
Morgan Stanley downgraded Toyota to Underweight, stating that the company's pivot to becoming a "new mobility leader" as announced early last year will come with higher R&D costs, lower margins, and lower free cash flows relative to consensus expectations. Morgan Stanley contends that "the market continues to underestimate the cost of transformation", adding that its value premium over other automakers will shrink over time.
FCAU Fiat Chrysler
$15.63

-0.39 (-2.43%)

11/01/19
REDB
11/01/19
UPGRADE
REDB
Neutral
Fiat Chrysler upgraded to Neutral from Sell at Redburn
Redburn analyst Charles Coldicott upgraded Fiat Chrysler to Neutral from Sell.
11/04/19
HSBC
11/04/19
UPGRADE
HSBC
Buy
Fiat Chrysler upgraded to Buy from Hold at HSBC
HSBC analyst Giulio Pescatore upgraded Fiat Chrysler to Buy from Hold.
11/12/19
EXAN
11/12/19
UPGRADE
Target $19.3
EXAN
Outperform
Fiat Chrysler upgraded to Outperform from Neutral at Exane BNP Paribas
Exane BNP Paribas analyst Stuart Pearson upgraded Fiat Chrysler to Outperform from Neutral with a price target of $19.30.
11/18/19
DBAB
11/18/19
DOWNGRADE
DBAB
Hold
Peugeot downgraded to Hold from Buy at Deutsche Bank
Deutsche Bank analyst Gaetan Toulemonde downgraded Peugeot (PUGOY) to Hold from Buy with a price target of 26 euros, down from 28 euros. The analyst believes Peugeot shareholders are "taking all of the risks" in the proposed merger with Fiat Chrysler (FCAU).
NSANY Nissan
$0.00

(0.00%)

05/14/19
MACQ
05/14/19
DOWNGRADE
MACQ
Underperform
Nissan downgraded to Underperform from Neutral at Macquarie
06/05/19
UBSW
06/05/19
UPGRADE
UBSW
Buy
Nissan upgraded to Buy from Sell at UBS
UBS upgraded Nissan to Buy from Sell and raised its price target on the shares to Y900 from Y800.

TODAY'S FREE FLY STORIES

AAPL

Apple

$318.66

3.33 (1.06%)

07:33
01/21/20
01/21
07:33
01/21/20
07:33
Periodicals
Apple scrapped plan for encrypting backups after FBI complained, Reuters reports »

Apple scrapped plans to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jan

MITO

Stealth Biotherapeutics

$3.04

-0.04 (-1.30%)

07:33
01/21/20
01/21
07:33
01/21/20
07:33
Hot Stocks
Stealth Biotherapeutics initiates human Phase 1 trial evaluating SBT-272 »

Stealth BioTherapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EHC

Encompass Health

$79.50

-0.77 (-0.96%)

07:31
01/21/20
01/21
07:31
01/21/20
07:31
Hot Stocks
Encompass Health plans to build rehabilitation hospital in South Carolina »

Encompass Health…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Feb

WPC

W.P. Carey

$83.13

-0.14 (-0.17%)

07:31
01/21/20
01/21
07:31
01/21/20
07:31
Hot Stocks
W.P. Carey announces $112M investment in U.K. Class-A logistics facility »

W. P. Carey announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INGR

Ingredion

$92.58

-0.355 (-0.38%)

, FISV

Fiserv

$120.69

0.46 (0.38%)

07:30
01/21/20
01/21
07:30
01/21/20
07:30
Hot Stocks
Ingredion appoints Tiffany Willis as VP, investor relations »

Ingredion (INGR)…

INGR

Ingredion

$92.58

-0.355 (-0.38%)

FISV

Fiserv

$120.69

0.46 (0.38%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Feb

  • 17

    Feb

TSLA

Tesla

$510.34

-3.065 (-0.60%)

07:29
01/21/20
01/21
07:29
01/21/20
07:29
Recommendations
Tesla analyst commentary  »

Tesla near-term…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jan

  • 24

    Feb

  • 23

    Mar

  • 23

    Mar

ORGS

Orgenesis

$5.40

0.36 (7.14%)

07:28
01/21/20
01/21
07:28
01/21/20
07:28
Hot Stocks
Orgenesis announces $9.2M private placement »

Orgenesis announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LAC

Lithium Americas

$4.12

-0.05 (-1.20%)

07:27
01/21/20
01/21
07:27
01/21/20
07:27
Hot Stocks
Lithium Americas receives notice of intent for Thacker Pass lithium project »

Lithium Americas…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

  • 12

    Mar

EQT

EQT Corporation

$8.25

-0.28 (-3.28%)

07:27
01/21/20
01/21
07:27
01/21/20
07:27
Upgrade
EQT Corporation rating change  »

EQT Corporation upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VERU

Veru

$4.19

0.07 (1.70%)

07:25
01/21/20
01/21
07:25
01/21/20
07:25
Recommendations
Veru analyst commentary  »

Veru price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NUAN

Nuance

$19.74

-0.02 (-0.10%)

07:24
01/21/20
01/21
07:24
01/21/20
07:24
Hot Stocks
Nuance announces Dragon Medical One availability in France, Belgium, Netherlands »

Nuance Communications…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

  • 05

    Feb

MRSN

Mersana Therapeutics

$8.05

0.42 (5.50%)

07:23
01/21/20
01/21
07:23
01/21/20
07:23
Recommendations
Mersana Therapeutics analyst commentary  »

Mersana Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EOG

EOG Resources

$85.35

-1.66 (-1.91%)

07:22
01/21/20
01/21
07:22
01/21/20
07:22
Upgrade
EOG Resources rating change  »

EOG Resources upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

KMDA

Kamada

$6.62

0.09 (1.38%)

07:21
01/21/20
01/21
07:21
01/21/20
07:21
Hot Stocks
Kamada announces $25M private placement with FIMI Opportunity Fund »

Kamada announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LTHM

Livent

$8.90

0.05 (0.57%)

07:21
01/21/20
01/21
07:21
01/21/20
07:21
Downgrade
Livent rating change  »

Livent downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KVHI

KVH Industries

$10.91

0.05 (0.46%)

, LMT

Lockheed Martin

$425.62

-0.055 (-0.01%)

07:20
01/21/20
01/21
07:20
01/21/20
07:20
Hot Stocks
Lockheed Martin selects KVH fiber optic gyro for infrared search, track system »

KVH Industries (KVHI)…

KVHI

KVH Industries

$10.91

0.05 (0.46%)

LMT

Lockheed Martin

$425.62

-0.055 (-0.01%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jan

BIDU

Baidu

$139.64

0.2 (0.14%)

07:18
01/21/20
01/21
07:18
01/21/20
07:18
Recommendations
Baidu analyst commentary  »

Baidu price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Feb

DIS

Disney

$144.25

-0.85 (-0.59%)

07:18
01/21/20
01/21
07:18
01/21/20
07:18
Hot Stocks
Disney+ moves up EMEA launch date to March 24 »

Disney's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Feb

RDHL

RedHill Biopharma

$6.16

0.11 (1.82%)

07:18
01/21/20
01/21
07:18
01/21/20
07:18
Hot Stocks
RedHill Biopharma discontinues promotion of Donnatal, EnteraGam »

RedHill Biopharma…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KSU

Kansas City Southern

$166.57

4.77 (2.95%)

07:17
01/21/20
01/21
07:17
01/21/20
07:17
Initiation
Kansas City Southern initiated  »

Benchmark starts Kansas…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BGNE

BeiGene

$170.73

2.85 (1.70%)

07:16
01/21/20
01/21
07:16
01/21/20
07:16
Hot Stocks
BeiGene says Phase 3 trial of tislelizumab meets primary endpoint »

BeiGene announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

CSX

CSX

$76.36

-0.39 (-0.51%)

07:16
01/21/20
01/21
07:16
01/21/20
07:16
Initiation
CSX initiated  »

Benchmark doesn't…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PDD

Pinduoduo

$39.43

-0.07 (-0.18%)

07:15
01/21/20
01/21
07:15
01/21/20
07:15
Recommendations
Pinduoduo analyst commentary  »

Pinduoduo price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MA

MasterCard

$323.60

3.36 (1.05%)

07:15
01/21/20
01/21
07:15
01/21/20
07:15
Initiation
MasterCard initiated  »

MasterCard initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jan

V

Visa

$204.71

3.765 (1.87%)

07:14
01/21/20
01/21
07:14
01/21/20
07:14
Initiation
Visa initiated  »

Visa initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jan

  • 30

    Jan

  • 11

    Feb

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.